Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00729560 · ClinicalTrials.gov registry record · NA

Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome

A NA study, sponsored by Virginia Commonwealth University.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT00729560: Clinical Trial NA study, sponsored by Virginia Commonwealth University.

NCT00729560 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00729560, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

Polycystic Ovary Syndrome (PCOS) is the major cause of infertility in the United States. Many women with PCOS demonstrate insulin resistance and a compensatory hyperinsulinemia.This is due to both an intrinsic form of insulin resistance unique to PCOS and, in many cases, acquired insulin resistance due to obesity. The importance of this observation lies in the fact that hyperinsulinemia appears to play an important pathogenetic role in the hyperandrogenism and anovulation of both obese and lean women with PCOS.

Primary Outcome

zero participants analyzed, no assays performed

Interventions

  • DRUG Placebo
  • DRUG Flutamide

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2008-07
Est. Completion 2012-02
Phase NA
Virginia Commonwealth University

558 total trials

Why NCT00729560 stopped before completion

NCT00729560 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00729560 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00729560 about?

NCT00729560 is a clinical study titled "Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome". Polycystic Ovary Syndrome (PCOS) is the major cause of infertility in the United States. Many women with PCOS demonstrate insulin resistance and a compensatory hyperinsulinemia.This is due to both an intrinsic form of insulin resistance unique to PCOS and, in many cases, acquired insulin resistance ...

What is the current status of trial NCT00729560?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-07. Estimated completion is 2012-02.

What interventions are being tested in trial NCT00729560?

The interventions under investigation include: Placebo (DRUG), Flutamide (DRUG).

Who is sponsoring clinical trial NCT00729560?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00729560's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00729560, the US trial registry maintained by the National Library of Medicine. NCT00729560 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.